Editorial Note: You can stay informed and receive our monthly Action Report newsletter directly to your inbox by joining the mailing list.
Welcome to the August issue of The Action Report! In this edition, we’re pleased to highlight stories of impact, welcome our newest members, share Coalition updates, and feature a new Leading By Example profile featuring Peter Park of Alchemy.
As we head into the year's second half, we’re excited to begin shaping our annual impact report and celebrate the many ways our members are driving progress across the six commitments. This is a great moment to reflect on how your company has stepped up this year and find new opportunities to get involved.
Welcome New Member: EpicWave Laboratory
Headed to USCHA? Join us for a drink! Catch up with Caroline and Mario, along with Coalition members, partners, and friends for happy hour on Thursday, Sept. 4 at 5:30-6:30 p.m. at the Lobby Bar of the Marriott Marquis Washington, DC.
Q3 National Coalition Meeting: We are excited to host our third virtual quarterly meeting for the National Coalition, where members can connect, share updates and best practices, and learn about opportunities to take action. Email endhiv@healthaction.org if you did not receive the calendar invite.
Atlanta Chapter Meeting: Interested in getting involved at the local level? Join our Atlanta Business Action to End HIV chapter meeting on Thursday, Sept. 25 at 11:30 a.m. at Portal Innovation at Science Square Labs.
Houston Chapter Meeting: We are pleased to host our quarterly Houston Business Action to End HIV meeting on Tuesday, Sept. 30 at 11:30 a.m. at the Hilton Garden Inn/Home2 Suites.
This newsletter is made possible with additional support from
“Leading by Example” is an ongoing series that highlights inspiring business leaders who are accelerating progress toward ending the HIV epidemic.
Founder & CEO
Alchemy
Alchemy flips the traditional pharmacy model by putting ownership in the hands of community clinics. What inspired this approach, and how does it advance the fight to end HIV in the U.S.?
The safety-net clinics we partner with — Ryan White Program grantees, STD clinics, and federally qualified health centers — are the critical frontline providers for HIV prevention and treatment in America. These specialized clinics offer an array of services that go above and beyond what traditional providers deliver to ensure patients have access to care.
And yet, so few of them have pharmacies inside their four walls — even as they manage a medical condition in HIV that depends on reliable access to medicines. I'm convinced that friction in the U.S. pharmacy system is one of the biggest barriers to improving HIV outcomes today.
A clinic-owned pharmacy model addresses so many of these access barriers. It brings medication access directly alongside the care providers patients trust, creating a true one-stop shop for patients to manage their HIV treatment or prevention regimen. By flipping ownership back into the hands of the clinics, we ensure that as much of every 340B dollar as possible stays local.
And it allows clinics, with support from innovation and infrastructure partners such as Alchemy, to maximize the reach of breakthrough innovations so patients benefit faster, more reliably, and where they need it most.
The newly established rural health fund could serve as a source of funding for HIV/AIDS services. States are the award winners, and providers and entities are encouraged to connect with states to discuss programs.
(KFF)
Timothy Panzl, a 62-year-old United Airlines flight attendant living with AIDS, is suing the company after being fired for what it called “excessive medical absences.” The lawsuit says his medical time off had been approved and that the airline discriminated against him based on age and disability. The airline says he exceeded its attendance points system and failed to properly call out sick.
(The Independent)
In this op-ed, author and activist Mary Fisher says she survived AIDS thanks to sustained scientific research and federal resources. She warns that current political decisions, like reducing funding for AIDS programs and research will result in more people facing unnecessary hardship.
(TIME)
CVS Health has declined to cover Gilead’s new twice-yearly HIV prevention drug, Yeztugo, on its commercial and ACA plans, citing clinical, financial, and regulatory factors. The decision has drawn criticism from AIDS advocates who see the drug as a breakthrough in ending the epidemic. Gilead expects most U.S. insurers to cover the drug within the next 18 months.
(Reuters)
Coalition Connect Happy Hour at USCHA
Q3 National Coalition Meeting (virtual)
Atlanta Chapter Meeting
11:30am - 2pm ET, in-person (Register)
Houston Chapter Meeting
11:30am - 2pm ET, in-person (Register)
The Health Action Alliance is solely responsible for the content of this page and maintains full editorial control of its resources.
U.S. Business Action to End HIV was founded in 2022 by the Health Action Alliance, with support from ViiV Healthcare, to mobilize a growing coalition of private sector partners committed to filling gaps and accelerating progress to help end HIV in the U.S. by 2030.
The Health Action Alliance is a unique collaboration between leading business, communications, and public health organizations to help employers navigate evolving health challenges, improve the health of workers, and engage with public health partners to build stronger, healthier communities. Founded in 2021 by the Ad Council, Business Roundtable, CDC Foundation, the de Beaumont Foundation, and the Robert Wood Johnson Foundation, HAA's network now includes more than 11,000 employers nationwide, reaching a quarter of U.S. workers.
Sign up for our newsletter to keep updated on HAA’s latest initiatives, insights and recommendations, and be first to receive new resources and event invitations.
Sign up